Prohibiting Tianeptine and Other Dangerous Products Act of 2026

Frank Pallone, Jr.

Democrat · NJ · Representative

Source: Congress.gov · FEC

No cosponsors on record. Bills can pass without cosponsors — this often means the sponsor introduced the bill alone, either because it's a messaging bill, a chairman's mark, or simply early in the legislative cycle.

Referred to the House Committee on Energy and Commerce.

2026-02-05

Source: Congress.gov

This bill would ban the sale and distribution of tianeptine, a drug sometimes sold as a dietary supplement or nootropic that can cause addiction and serious health problems, along with other similar dangerous products. The ban would apply to retailers, online sellers, and manufacturers across the country, protecting consumers—especially young people—from accessing these substances that are not approved by the FDA for human consumption. The measure aims to close loopholes that currently allow these drugs to be marketed and sold legally despite their health risks.

AI-assisted summary generated from the official bill metadata (title, subjects, actions) sourced from Congress.gov. Cached and reviewed. Always verify against the official text linked below.

• HR1493To reauthorize and make improvements to Federal programs relating to the prevention, detection, and treatment of traumatic brain injuries, and for other purposes.
  Reported by Committee · 2026-05-21
• HRES1305Congratulating the Jewish War Veterans on the 130th anniversary of the organization's founding and honoring their commitment to Jewish war veterans.
  Referred to Committee · 2026-05-19
• HR8385Food Labeling Modernization Act of 2026
  Referred to Committee · 2026-04-20
• HR1431To designate the facility of the United States Postal Service located at 2407 State Route 71, Suite 1, in Spring Lake, New Jersey, as the "James J. Howard Post Office".
  Passed House · 2026-04-15